Prognostic Factors for Malignant Transformation in Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma - Wikidata - awgldk - TriplyDB

Prognostic Factors for Malignant Transformation in Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Prognostic Factors for Malignant Transformation in Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

http://www.wikidata.org/entity/Q56853465

about

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance Smoldering multiple myeloma requiring treatment: time for a new definition?Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendations.The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.Clinical implications of c-maf expression in plasma cells from patients with multiple myeloma.Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease.Prognostic significance of focal lesions and diffuse infiltration on MRI for multiple myeloma: a meta-analysis.Incidental finding of monoclonal gammopathy in blood donors: a follow-up study.Management of paraproteinaemia.Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma.Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS.Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology Occurrence of multiple myeloma in the head and neck: a report of two cases.Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120).Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma Short-term outcome and quality of life in kidney transplant recipient with monoclonal gammopathy.Genomic analysis of high-risk smoldering multiple myeloma.The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma.Analytical Criticalities Associated to Different Immunological Methods for Serum Free Light Chain Detection in Plasma Cell Dyscrasias: A Description of Particular Clinical Cases.Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management.Immunoparesis defined by heavy+light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosis.Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis.A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance.Response: Multiple myeloma is universally preceded by a prolonged premalignant stage: novel clinical insights and future directions.Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.Abnormal Plasma Cell Disorders in Refinery Waste Workers Timing of treatment of smoldering myeloma: delay until progression

P2860

Q24650785-AFD305F5-0740-41A5-92B1-97929F130AF5 Q24669898-0D76771F-00A8-4374-B1E0-3FE82F7840A6 Q26996579-098656AF-3781-455B-BC7E-1B205BFF47AA Q33628815-6D81D625-5158-44C3-B47D-2F52810A2D1D Q33695919-855A56E9-2CC5-45F1-A43C-0E3E0C195016 Q33733709-7F6C8778-F9DE-44AA-9544-71688202CFE5 Q34184698-EAB277AD-1213-4EE7-AC1A-EF1DCA094371 Q34316559-96DAA446-0CC8-4848-831C-F5C9125CCC03 Q36123252-20207E84-95AD-41D6-A08B-1E8216697DB6 Q36159988-A4CF5602-822B-40FE-AC36-BBA4E3932A5B Q36778432-5A8AFF98-FA2B-4947-98BB-3E88AA88F83F Q36799760-4A12651F-7163-4D50-B3DA-910166ADF7FA Q36950805-74D27746-AC5C-4068-9F24-42298966A43E Q36963203-037F7769-522D-41CB-BC82-82D697D95E88 Q37380699-DF196847-3E92-4B6D-855A-F47FE1B85FB0 Q37429722-2DF17AE9-EE7B-459C-81AF-D3CD58278404 Q37489018-0693D0F9-FEA3-420F-BE90-800D85144E1D Q37582168-AB7F0613-3716-4C83-9260-2B37916554CC Q37706308-95277E20-4C91-4852-ADFF-9FAB943B3DBA Q38219408-35644BD4-75E2-4D85-9548-DECF9FEC43D7 Q40210857-30CB837F-7ABB-4CCD-AEBB-84248E72AB87 Q41847877-35E03B57-6247-4525-8A28-EDD4ABFAACC6 Q42250752-A9F6DAC4-8BAC-4F64-9587-FBD384B8361E Q42356395-02BE7A49-CA12-4CB9-9BBB-24B6A4BB98A3 Q47642719-B880E133-1B38-4B6C-85B4-81173BD45741 Q47679443-C9FACE0E-0359-445A-A9FC-74BCE2EBA6D6 Q48156924-6EA725C2-7099-4C22-A2A7-0E4D14E6BD93 Q48310565-9B7A863A-15F9-43A4-8488-5ABCF39D9411 Q49996546-2F8CAAB8-C0CE-4AF7-A257-01CF7C380D96 Q50000214-9F5BF76C-5266-46F0-A7B6-590903909BED Q53286119-2B0EA3C6-FFB6-4106-857C-B6E25DE69FAE Q55452570-1974699C-939B-499F-9FAD-6943209A39D9 Q58089507-47EC71DB-9AD2-48DD-8CE0-CB21AB53D386 Q59137902-F57695AD-42F4-4903-A414-5BE46FE76641

P2860

Prognostic Factors for Malignant Transformation in Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

http://www.wikidata.org/entity/Q56853465

description

im März 2002 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 2002

@uk

name

Prognostic Factors for Maligna ...... nd Smoldering Multiple Myeloma

@en

Prognostic Factors for Maligna ...... nd Smoldering Multiple Myeloma

@nl

type

label

Prognostic Factors for Maligna ...... nd Smoldering Multiple Myeloma

@en

Prognostic Factors for Maligna ...... nd Smoldering Multiple Myeloma

@nl

prefLabel

Prognostic Factors for Maligna ...... nd Smoldering Multiple Myeloma

@en

Prognostic Factors for Maligna ...... nd Smoldering Multiple Myeloma

@nl

P1433

Q56853465-C946DFDE-468A-4A70-8FAD-EE5F7524293E

P1476

Q56853465-770942C7-B787-42A8-883C-111F3ADFD525

P2093

Q56853465-1FEF9759-EFDA-495B-B096-FB75234EB276

Q56853465-41FB3D82-8C12-41DA-91B0-8437AE169DA3

Q56853465-47D6B043-5844-43A7-A496-9EB8BE6EC433

Q56853465-4B2B174B-9BF7-416A-BD0B-3DAB12C4B968

Q56853465-5F2830C5-EA0A-438A-8ED5-C3107C0D48D0

Q56853465-87AB6FC4-C91C-4FC6-8DBA-D6635245A98E

Q56853465-8B0EF59F-F12A-4E33-B1CE-7BCB778BC56F

Q56853465-AAE3890A-CC24-4739-821B-B63387E76366

Q56853465-C346DE49-D79E-4A0C-BF56-4601E75CD309

Q56853465-D9FB0170-CFB7-4A6E-BD9C-CC0BA6CAD185

P304

Q56853465-AB145B09-B651-4103-AA12-024F58FD198C

P31

Q56853465-1B9E5237-0461-4669-8BE7-85B7C73FEDC4

P356

Q56853465-11DAA851-AEE6-4595-8625-6FD7C3ABD895

P407

Q56853465-1D8CA8A0-B615-471B-9B50-34B4F7885EEA

P433

Q56853465-775D5B19-5178-4E96-80FB-F1F4EE2AECA7

P478

Q56853465-EB4160F1-7526-46EF-84E4-856003F03802

P577

Q56853465-A04D7283-1F9B-43CE-8135-DF430E16805D

P698

Q56853465-65BBE264-B614-452F-8696-D108226A18EC

P356

JCO.2002.20.6.1625

P1433

Journal of Clinical Oncology

P1476

Prognostic Factors for Maligna ...... nd Smoldering Multiple Myeloma

@en

P2093

Anna Maria Nosari

http://www.w3.org/2001/XMLSchema#string

Catherine Klersy

http://www.w3.org/2001/XMLSchema#string

Clara Cesana

http://www.w3.org/2001/XMLSchema#string

Enrica Morra

http://www.w3.org/2001/XMLSchema#string

Ester Pungolino

http://www.w3.org/2001/XMLSchema#string

Livio Gargantini

http://www.w3.org/2001/XMLSchema#string

Luciana Barbarano

http://www.w3.org/2001/XMLSchema#string

Marina Valentini

http://www.w3.org/2001/XMLSchema#string

Monica Crugnola

http://www.w3.org/2001/XMLSchema#string

Simonetta Granata

http://www.w3.org/2001/XMLSchema#string

P304

1625-1634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2002.20.6.1625

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2002-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11896113

http://www.w3.org/2001/XMLSchema#string